• SENSEX 73,377.24
    -229.51 (--0.31%)
  • BANKNIFTY 54,366.70
    79.35 (+0.15%)
  • TVS Holdings
    11,337.15 16,150.00(%)
  • NSE
    1,774.00 1,878.00(%)
  • Ather Energy
    1,702.00 1,741.90(%)
  • Apollo Micro Sys
    446.80 466.70(%)
  • LIC Housing Fin.
    512.00 598.00(%)
  • DLF
    672.55 786.40(%)
  • Persistent Systems
    5,695.50 4,242.65(%)
  • Sona BLW Precis.
    863.90 843.90(%)
  • Adani Enterp.
    2,434.60 1,753.45(%)
  • Federal Bank
    348.20 364.95(%)
  • Reliance Industries
    1,184.00 1,152.30(%)
  • OneSource Speci.
    1,606.35 1,924.00(%)
  • Sky Gold & Diam.
    965.00 1,083.00(%)
  • HDFC Bank
    680.15 682.00(%)
  • SBI Life Insuran
    1,626.75 1,609.20(%)
  • Torrent Pharma.
    4,649.20 5,249.95(%)
  • Tonbo Imaging
    1,300.00 1,331.45(%)
  • Max Healthcare
    857.00 1,196.50(%)
  • GE Vernova T&D
    4,025.00 5,650.00(%)
  • NTPC
    306.70 414.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Granules India Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 12632.0
  • ISIN : INE101D01020
820.55 26 (3.25%)
  • As on 27 Oct 2026 (EOD)
  • Today’s Low

    792.25
  • Today’s High

    825.95
  • Open

    792.90
  • Perv Close

    794.75
  • 52W Low

    529.85
  • 52W High

    923.65

Key Indicators

  • P/E(TTM)

    55.51

  • Mar.Cap (₹Cr.)

    22,382.95

  • Div & Yield %

    0.19

  • Book Value(₹)

    201.44

  • Debt-Equity Ratio

    3.25

  • AGM Date

    26-Oct-2026

  • EPS

    14.77

  • P/E Ratio

    55.51

Financials Ratios

  • Debt-Equity Ratio

    0.40

  • Mar.Cap (₹Cr.)

    22,382.95

  • RONW (%)

    13.38

  • ROCE (%)

    15.22

Score Board

  • Equity (₹ in Cr.)

    27.28

  • BV (₹)

    201.40

  • Sales( ₹ in Cr.)

    3,473.96

  • NP (in Cr.)

    409.82

  • NP Var(%)

    45.0

  • Div%

    175.0

  • CPS (₹)

    21.10

  • EPS (₹)

    15.00

  • Traded Value (₹ in Lakhs)

    22,363.85

  • 52 Week High

    923.65

  • 52 Week Low

    529.85

  • Price BSE

    820.0

  • Price NSE

    821.00

  • Market Capital( in Cr.)

    22,363.85

  • P/C Ratio

    38.90

  • P/E Ratio

    54.60

  • Price Vs.BV

    15.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 3,473.96 3,030.16 3,755.09 3,931.20 3,238.44 3,134.98
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 3,473.96 3,030.16 3,755.09 3,931.20 3,238.44 3,134.98
Other Income 49.80 71.43 5.78 9.93 17.51 13.72
Stock Adjustments -7.68 29.80 20.21 -61.52 106.41 -7.45
Total Income 3,516.08 3,131.39 3,781.08 3,879.61 3,362.36 3,141.25
EXPENDITURE :            
Raw Materials 1,505.27 1,373.90 1,927.12 2,099.93 1,864.16 1,502.19
Power and Fuel Cost 100.19 90.31 93.01 88.95 69.91 65.51
Employee Cost 383.91 342.20 332.99 278.19 247.86 234.36
Other Manufacturing Expenses 162.29 145.65 142.30 117.40 121.37 110.80
Selling and Administration Expenses 555.47 510.21 428.83 420.15 364.58 320.46
Miscellaneous Expenses 47.23 32.90 49.69 26.82 32.31 32.83
Employee Benefit Expenses 383.91 342.20 332.99 278.19 247.86 234.36
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 2,754.36 2,495.16 2,973.93 3,031.44 2,700.20 2,266.16
Operating Profit 761.73 636.23 807.14 848.17 662.16 875.09
Interest 61.44 62.78 72.00 38.67 16.35 23.77
Gross Profit 700.29 573.45 735.14 809.50 645.81 851.32
Depreciation 164.47 146.23 143.85 145.56 126.16 118.45
Profit Before Tax 535.82 427.22 591.29 663.94 519.65 732.87
Current Tax 135.16 109.88 150.61 170.21 133.51 197.06
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.01 -1.99 4.77 -5.05 -0.38 -16.97
Reported Net Profit 400.67 319.34 435.92 498.79 386.52 552.78
Extraordinary Items -9.16 36.38 -1.71 -1.03 -3.55 -0.27
Adjusted Net Profit 409.83 282.96 437.63 499.82 390.07 553.05
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 2,891.24 2,608.26 2,208.65 1,728.49 1,379.14 851.10
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 36.40 36.35 36.31 18.62 37.17 24.75
P & L Balance carried down 3,255.51 2,891.24 2,608.26 2,208.65 1,728.49 1,379.14
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 175.00 150.00 150.00 150.00 150.00 150.00
Dividend Per Share(Rs) 1.75 1.50 1.50 1.50 1.50 1.50
Earnings Per Share-Unit Curr 16.17 13.17 17.99 20.61 15.58 22.32
Earnings Per Share(Adj)-Unit Curr 16.17 13.17 17.99 20.61 15.58 22.32
Book Value 162.77 140.31 128.36 111.53 102.04 87.32
Book Value(Adj)-Unit Curr 162.77 140.31 128.36 111.53 102.04 87.32

Shareholding Pattern

  • Promoter Group

    37.39%

  • Public Share Holding

    62.61%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 846,878 846,878.00 846,878 846,878
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 846,878 0.31 846,878 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 3,552,557 1.30 3,552,557 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 97,586,996 35.78 97,586,996 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 101,139,553 37.08 101,139,553 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 55,231,975 20.25 55,231,975 247
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 18,923,341 6.94 18,923,341 11
Mutual Funds / UTI 11,615,466 4.26 11,615,466 27
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 11,270,790 4.13 11,270,790 49
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 97,041,572 35.58 97,041,572 334
2] Non Institution
Bodies Corporate 15,056,799 5.52 15,056,799 970
Clearing Members 18,054 0.01 18,054 5
Directors of their Relatives 3,451,085 1.27 3,451,085 3
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 4,272,424 1.57 4,272,424 5,736
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,716,166 0.63 1,716,166 2,283
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 14,332,895 5.25 14,332,895 20
Individuals holding nominal share capital up to Rs. 1 lakh 34,598,365 12.68 34,526,965 172,657
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 183 0.00 183 3
Others 298,853 0.11 298,853 1
Sub Total 73,751,824 27.04 73,680,424 181,679
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 272,779,827 100.00 272,708,427 182,022

Company Background

Granules India LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Granules India Ltd
  • BSE Code : 12632.0
  • ISIN : INE101D01020
  • Incorporation Year

    1991

  • Registered Office

    15th Floor Granules Tower
    Botanical Garden Road Kondapur, Hyderabad,
    Telangana-500084

  • Telephone

    91-40-69043500

  • FAX

    91-40-23115145

  • Chairman

    C Krishna Prasad

  • Managing Director

    C Krishna Prasad

  • Company Secretary

    Chaitanya Tummala

  • Auditor

    S R Batliboi & Associates LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Granules India Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Granules India 819.85 3,523.76 3,473.96 55.51 12.46
Abbott India 25,222.05 7,217.19 6,929.05 33.19 43.78
Astrazeneca Phar 6,074.75 2,304.07 2,275.58 89.53 27.86
Glaxosmi. Pharma 2,448.15 3,932.76 3,790.20 39.11 58.17
Novartis India 1,788.65 393.10 354.33 45.17 15.94
Cipla 1,353.00 20,102.60 18,979.95 35.56 13.88
Bliss GVS Pharma 617.15 773.53 729.81 57.36 12.51
Amrutanjan Healt 490.00 520.13 502.55 26.25 24.16
Fermenta Biotec. 445.65 474.15 450.25 20.81 18.77
Guj. Themis Bio. 337.75 168.25 165.82 90.31 18.05
Ambalal Sarabhai 35.99 19.52 3.94 66.65 6.77